Germany
· Delayed Price · Currency is EUR Gaush Meditech Statistics
Total Valuation
Gaush Meditech has a market cap or net worth of EUR 90.32 million. The enterprise value is 95.90 million.
| Market Cap | 90.32M |
| Enterprise Value | 95.90M |
Important Dates
The next estimated earnings date is Friday, August 22, 2025.
| Earnings Date | Aug 22, 2025 |
| Ex-Dividend Date | Jun 23, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.14% |
| Shares Change (QoQ) | -0.20% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 52.63M |
Valuation Ratios
The trailing PE ratio is 7.39.
| PE Ratio | 7.39 |
| Forward PE | n/a |
| PS Ratio | 0.48 |
| PB Ratio | 0.43 |
| P/TBV Ratio | 1.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 7.84 |
| EV / Sales | 0.56 |
| EV / EBITDA | 3.22 |
| EV / EBIT | 4.09 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.35.
| Current Ratio | 2.25 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 2.23 |
| Debt / FCF | n/a |
| Interest Coverage | 5.30 |
Financial Efficiency
Return on equity (ROE) is 5.39% and return on invested capital (ROIC) is 5.40%.
| Return on Equity (ROE) | 5.39% |
| Return on Assets (ROA) | 4.50% |
| Return on Invested Capital (ROIC) | 5.40% |
| Return on Capital Employed (ROCE) | 9.47% |
| Revenue Per Employee | 213,826 |
| Profits Per Employee | 13,831 |
| Employee Count | 884 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.31 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.67% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -71.67% |
| 50-Day Moving Average | 0.79 |
| 200-Day Moving Average | 1.10 |
| Relative Strength Index (RSI) | 37.22 |
| Average Volume (20 Days) | 998 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gaush Meditech had revenue of EUR 189.02 million and earned 12.23 million in profits. Earnings per share was 0.08.
| Revenue | 189.02M |
| Gross Profit | 87.79M |
| Operating Income | 25.74M |
| Pretax Income | 20.55M |
| Net Income | 12.23M |
| EBITDA | 32.73M |
| EBIT | 25.74M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 68.68 million in cash and 73.08 million in debt, giving a net cash position of -4.40 million.
| Cash & Cash Equivalents | 68.68M |
| Total Debt | 73.08M |
| Net Cash | -4.40M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 210.17M |
| Book Value Per Share | 1.41 |
| Working Capital | 84.55M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 46.44%, with operating and profit margins of 13.62% and 6.47%.
| Gross Margin | 46.44% |
| Operating Margin | 13.62% |
| Pretax Margin | 10.87% |
| Profit Margin | 6.47% |
| EBITDA Margin | 17.31% |
| EBIT Margin | 13.62% |
| FCF Margin | n/a |
Dividends & Yields
Gaush Meditech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.14% |
| Shareholder Yield | 0.14% |
| Earnings Yield | 13.54% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |